These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35577626)

  • 1. No apparent association between mRNA COVID-19 vaccination and venous thromboembolism.
    Nicholson M; Goubran H; Chan N; Siegal D
    Blood Rev; 2022 Nov; 56():100970. PubMed ID: 35577626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria.
    Shaw RJ; Doyle AJ; Millen EA; Stowe J; Tessier E; Andrews N; Miller E;
    Vaccine; 2023 Aug; 41(36):5330-5337. PubMed ID: 37495490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic outcomes in patients in a large clinical enterprise following COVID-19 vaccination.
    Patterson WM; Greene BD; Tefera L; Bena J; Milinovich A; Mehta N; Chung MK; Kapadia S; Svensson LG; Cameron SJ
    J Thromb Thrombolysis; 2023 Apr; 55(3):426-431. PubMed ID: 36653575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Uncommon thrombotic complications after SARS-CoV-2 vaccination].
    Musil D
    Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L
    Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic events following the BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech) in Aotearoa New Zealand: A self-controlled case series study.
    Walton M; Tomkies R; Teunissen T; Lumley T; Hanlon T
    Thromb Res; 2023 Feb; 222():102-108. PubMed ID: 36634464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
    Saluja P; Gautam N; Yadala S; Venkata AN
    Thromb Res; 2022 Jun; 214():115-121. PubMed ID: 35533526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
    Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
    JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination.
    Iba T; Levy JH
    Trends Cardiovasc Med; 2022 Jul; 32(5):249-256. PubMed ID: 35202800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    Hippisley-Cox J; Patone M; Mei XW; Saatci D; Dixon S; Khunti K; Zaccardi F; Watkinson P; Shankar-Hari M; Doidge J; Harrison DA; Griffin SJ; Sheikh A; Coupland CAC
    BMJ; 2021 Aug; 374():n1931. PubMed ID: 34446426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination.
    Jacobs JW; Booth GS; Adkins BD
    Ann Hematol; 2023 Apr; 102(4):955-959. PubMed ID: 36795118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of venous thromboembolism after COVID-19 vaccination.
    Houghton DE; Wysokinski W; Casanegra AI; Padrnos LJ; Shah S; Wysokinska E; Pruthi R; Ashrani A; Sridharan M; Baumann-Kreuziger L; McBane R; Padmanabhan A
    J Thromb Haemost; 2022 Jul; 20(7):1638-1644. PubMed ID: 35398975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry.
    Bikdeli B; Jiménez D; Demelo-Rodriguez P; Galeano-Valle F; Porras JA; Barba R; Ay C; Malý R; Braester A; Imbalzano E; Rosa V; Lecumberri R; Siniscalchi C; Fidalgo Á; Ortiz S; Monreal M; For The Riete Investigators
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
    Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
    JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
    Ruzicka M; Wurm S; Lindner L; Dreyling M; von Bergwelt-Baildon M; Boeck S; Giessen-Jung C; Milani V; Stemmler JH; Subklewe M; Weigert O; Spiekermann K
    Infection; 2023 Feb; 51(1):231-238. PubMed ID: 36195695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk and incident venous thromboembolism in middle-aged and older adults following COVID-19 vaccination.
    Xie J; Prats-Uribe A; Gordillo-Marañón M; Strauss VY; Gill D; Prieto-Alhambra D
    J Thromb Haemost; 2022 Dec; 20(12):2887-2895. PubMed ID: 36111372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults.
    Harris DA; Hayes KN; Zullo AR; Mor V; Chachlani P; Deng Y; McCarthy EP; Djibo DA; McMahill-Walraven CN; Gravenstein S
    JAMA Netw Open; 2023 Aug; 6(8):e2326852. PubMed ID: 37531110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
    Matsumura A; Katsuki K; Akimoto M; Sakuma T; Nakajima Y; Miyazaki T; Fujisawa S; Nakajima H
    Rinsho Ketsueki; 2021; 62(11):1639-1642. PubMed ID: 34866090
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.